Evidence map›Paper›PMID 23222816›Full record

ArticleCarcinogenesis2013

Targeted expression of ornithine decarboxylase antizyme prevents upper aerodigestive tract carcinogenesis in p53-deficient mice.

David J Feith, Anthony E Pegg, Louise Y Y Fong

Open access · bronzeAbstract read
In one paragraph

Article in Carcinogenesis, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

David J FeithDepartment of Cellular and Molecular Physiology, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA. dfeith@psu.edu
Anthony E Pegg
Louise Y Y Fong
Pennsylvania State University · USThomas Jefferson University · US

Funding

MAMMALIAN POLYAMINE METABOLISMR01CA018138 · NCI · UNIVERSITY OF VIRGINIA · PI FEITH, DAVID J. · 1985 to 2015
$2.8M
Chemoprevention of upper aerodigestive tract cancer by dietary zincR01CA118560 · NCI · THOMAS JEFFERSON UNIVERSITY · PI FONG, LOUISE Y.Y. · 2006 to 2017
$2.7M
NCI NIH HHS R01 CA018138NCI NIH HHS R01CA018138NCI NIH HHS R01CA118560
6 · The paper itself

Abstract

Upper aerodigestive tract (UADT) cancers of the oral cavity and esophagus are a significant global health burden, and there is an urgent need to develop relevant animal models to identify chemopreventive and therapeutic strategies to combat these diseases. Antizyme (AZ) is a multifunctional negative regulator of cellular polyamine levels, and here, we evaluate the susceptibility of keratin 5 (K5)-AZ transgenic mice to tumor models that combine chemical carcinogenesis with dietary and genetic risk factors known to influence human susceptibility to UADT cancer and promote UADT carcinogenesis in mice. First, p53(+/-) and K5-AZ/p53(+/-) (AZ/p53(+/-)) mice were placed on a zinc-deficient (ZD) or zinc-sufficient (ZS) diet and chronically exposed to 4-nitroquinoline 1-oxide. Tongue tumor incidence, multiplicity and size were substantially reduced in both ZD and ZS AZ/p53(+/-) mice compared with p53(+/-). AZ expression also reduced progression to carcinoma in situ or invasive carcinoma and decreased expression of the squamous cell carcinoma biomarkers K14, cyclooxygenase-2 and metallothionein. Next, AZ-expressing p53(+/-) and p53 null mice were placed on the ZD diet and treated with a single dose of N-nitrosomethylbenzylamine. Regardless of p53 status, forestomach (FST) tumor incidence, multiplicity and size were greatly reduced with AZ expression, which was also associated with a significant decrease in FST epithelial thickness along with reduced proliferation marker K6 and increased differentiation marker loricrin. These studies demonstrate the powerful tumor suppressive effects of targeted AZ expression in two distinct and unique mouse models and validate the polyamine metabolic pathway as a target for chemoprevention of UADT cancers.

Indexed as

4-Nitroquinoline-1-oxideAnimalsCarcinoma, Squamous CellCell ProliferationCell Transformation, NeoplasticDimethylnitrosamineEpitheliumEsophageal NeoplasmsGastric MucosaHead and Neck NeoplasmsMiceMice, Inbred C57BLMice, TransgenicPolyaminesProteinsQuinolones4-Nitroquinoline-1-oxide4-nitroquinolone-1-oxideDimethylnitrosaminenitrosobenzylmethylamineornithine decarboxylase antizymePolyaminesProteinsQuinolonesTumor Suppressor Protein p53

Identifiers

PMID23222816
PMCPMC3581602
OpenAlexW2124858728

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.